Carl Feinstein, M.D. Dr. Feinstein specializes in child and adolescent psychiatry, with an emphasis on developmentally-disabled individuals. He has studied psychiatric disorders related to disabilities such as blindness, deafness, and mental retardation. His work has also explored psychiatric disorders linked to chronic diseases such as cystic fibrosis, diabetes, and arthritis.

Positions

• Director, Division of Child Psychiatry and Child Development, Stanford University
• Professor, Dept. of Psychiatry and Behavioral Sciences, Stanford University School of Medicine

Education

• M.D., 1968, State University of New York, Downstate Medical Center, Brooklyn, NY

Relevant Publications

• Feinstein C, Singh S. Social phenotypes in neurogenetic syndromes. Child Adolesc Psychiatr Clin N Am. 2007;16(3):631-647.
• Gothelf D, Feinstein C, Thompson T, et al. Neuropsychiatric risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry. 2007;164:663-669.
• Debbane M, Glaser B, David MK, Feinstein C, Eliez E. Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications. Schizophr Res. 2006;84:187-193.
• Gothelf D, Eliez S, Thompson T, et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci. 2005;8:1500-1502.
• Feinstein C, Eliez E, Blasey C, Reiss A. Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: Usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry. 2002;43:312-318.